European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by
about
Fibrates for type 2 diabetes mellitusFibrates for type 2 diabetes mellitusOmega 3 fatty acids for prevention and treatment of cardiovascular diseaseVTE Risk assessment - a prognostic Model: BATER Cohort Study of young womenComparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS studyRelation between awareness of circulatory disorders and smoking in a general population health examination"Obesity paradox" in coronary artery diseasePrevalence dependent calibration of a predictive model for nasal carriage of methicillin-resistant Staphylococcus aureusMediterrAsian Diet Products That Could Raise HDL-Cholesterol: A Systematic ReviewCardiopulmonary exercise testing, prehabilitation, and Enhanced Recovery After Surgery (ERAS)Measurement of coronary calcium scores or exercise testing as initial screening tool in asymptomatic subjects with ST-T changes on the resting ECG: an evaluation studyThe relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACHLow-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: data from the Chinese Longitudinal Healthy Longevity Survey.Higher prevalence of smoking and lower BMI, waist circumference, cholesterol and triacylglyceride levels in Prague's homeless compared to a majority of the Czech populationThe (cost-)effectiveness of an individually tailored long-term worksite health promotion programme on physical activity and nutrition: design of a pragmatic cluster randomised controlled trial.Healthy hearts--a community-based primary prevention programme to reduce coronary heart disease.Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13).Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population - a cross sectional study.Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial.Screening families of patients with premature coronary heart disease to identify avoidable cardiovascular risk: a cross-sectional study of family members and a general population comparison group.Post-prandial lipid levels for assessing target goal achievement in type 2 diabetic patients taking statin.Prevalence of Cardiovascular Risk Factors among Tile and Ceramic Workers in Yazd, Iran.Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study.An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.Classical risk factors of cardiovascular disease among Chinese male steel workers: a prospective cohort study for 20 years.Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study.Atypical presentation of acute and chronic coronary artery disease in diabetics.Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity.Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness.The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial.Prevalence and determinants of electrocardiographic abnormalities in African Americans with type 2 diabetes.A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk.The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers.Impact of health counselling on cardiovascular disease risk in middle aged men: influence of socioeconomic statusA marketing perspective on disseminating evidence-based approaches to disease prevention and health promotion.Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA studyAbsence of increase in carotid artery intima-media thickness in infants of diabetic mothers.Observational study of lipid profile and LDL particle size in patients with metabolic syndrome.Prevalence and management of cardiovascular risk factors in Portuguese living in Portugal and Portuguese who migrated to Switzerland.
P2860
Q24195161-AC34444C-29EF-4D97-9381-9CB5AC278612Q24204016-150746CD-3C8E-42E5-8803-68E8D0E39FC6Q24245810-D486D829-D1EE-479F-A09C-9135B9FE1A82Q24795738-655948F8-8A30-49C6-BDF0-24C986FED2FBQ24814804-D293205D-16B3-4516-AEA8-9BFC097236AAQ25256825-F706EB30-40B0-492E-BB64-2F8261125FF4Q26777873-A58E87A5-D2AB-4B5B-B4CD-F31BD29B0E12Q27496670-02F2F57B-0308-4686-968D-AE19350860B8Q28070287-97B73677-D816-4BCD-A409-45597500A263Q28083172-2A98FC8F-C6B7-4636-8C98-A332DBA42FB6Q28218377-A3DE9EE9-80E5-4485-8FCB-4B6DAFAA1030Q30434292-1C6CF299-41BC-4EDC-9B38-02BFCEF228BAQ30885171-914379CB-A5C3-4C54-ACD2-985D198B4C8AQ33281302-B35A5132-84DC-406C-81C4-D973F31EF385Q33299947-03B7554C-9C51-477F-A696-7774BE473ED7Q33355191-625E8DD6-4B1D-4315-90AA-AAF068438319Q33376862-88C3A710-2254-4B08-A5FE-2A1E315DB920Q33521206-CEA106D5-9993-42DC-9E74-6A0066872917Q33533901-4964FC21-43A4-4EC9-979B-1B6E32650784Q33571936-ED526F05-187A-4DFD-8F08-60AC5727B9ACQ33575443-8E739CAB-71E9-4393-8A59-AE26B0752C1EQ33680229-35F9CAA2-2F50-48A9-BBCE-DD8E253BC47FQ33710984-E6E03309-CD3E-4ED2-BEE4-FE0CC78AEB89Q33747018-8DB1DE56-D1EC-497A-B638-8577621CC9B1Q33925329-A0103B62-B562-4338-ACBD-BE4923AB4516Q33942455-67DF76E0-50C4-4C8E-A776-E7254C1FFC52Q33944736-6BAEAB97-4FFF-4CA0-B182-6744981AE3F2Q34179055-14B6EF46-55B3-4DCD-AF06-F3CD29788592Q34230667-B2B420CE-38BB-4D2D-B3D3-335214CF0003Q34346294-4FA8ACBD-14D8-4AA6-B9A1-9000DF8E3116Q34410047-3B2CBB06-260A-45D1-B82A-3DEC5398C292Q34625132-FB540D81-6C57-48BA-9B45-EB3091B555B7Q34703804-DBE63CAE-984B-4BF3-BC85-34C4A74C3E7DQ35060159-A6574CC8-30E1-4E20-A044-E6C65515A395Q35097657-9C76057D-A67D-4640-BD37-DA11C472C871Q35134481-91882B6D-5161-49D6-AFE3-85B765A003EAQ35187425-C2A41598-0EC0-492C-AD96-C564ACA0EAF1Q35251644-C4149A7C-51DC-44E9-9655-1B62CC0A1C35Q35338399-D5FF6364-1E84-4698-86AC-96219BF78C5DQ35356380-BABF9E6C-6789-4536-AD13-4EE170CD0A61
P2860
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
European guidelines on cardiov ...... ives of eight societies and by
@en
European guidelines on cardiov ...... revention in clinical practice
@nl
type
label
European guidelines on cardiov ...... ives of eight societies and by
@en
European guidelines on cardiov ...... revention in clinical practice
@nl
prefLabel
European guidelines on cardiov ...... ives of eight societies and by
@en
European guidelines on cardiov ...... revention in clinical practice
@nl
P2093
P50
P1476
European guidelines on cardiov ...... ives of eight societies and by
@en
P2093
Carlos Brotons
David Wood
Ettore Ambrosioni
European Society of Cardiology Committee for Practice Guidelines
Ian Graham
José L Rodicio
Kalevi Pyörälä
Knut Borch-Johnsen
Kristina Orth-Gomér
P304
P356
10.1097/00149831-200308000-00004
P577
2003-08-01T00:00:00Z